A retrospective review of women treated for breast cancer diagnosed in 2010-2016 demonstrated the effects of delays in time to surgery for DCIS and cT1-2N0 disease.
Survey results show that parents are in agreement with their adolescents with cancer regarding some concerns but not all.
The association between functional impairment and symptom burden was shown to be predictive of outcomes for older patients with advanced cancer.
Researchers feed a series of scenarios involving poor or negative outcomes into various hospitals’ EHR systems to measure their safety in detecting dangerous medication errors.
Histology-tailored neoadjuvant chemotherapy failed to show superiority compared with standard neoadjuvant chemotherapy in patients with high-risk STS.
Clinicians may be underappreciating the extent of adverse events in women with cervical and endometrial cancer who undergo radiotherapy.
The multicenter, randomized REACH2 trial demonstrated that ruxolitinib is efficacious and safe for patients with aGVHD after allogeneic stem cell transplantation.
Men with metastatic castration-resistant prostate cancer and symptomatic bone metastases had longer survival times when they received radium-223 as first-line therapy compared with those who received the drug as third-line therapy.
A survey of patients and healthcare providers revealed gaps in discussions and documentation of fertility preservation options for young adult patients with cancer and potential barriers to overcome to improve this care.
Researchers suggest appropriate monitoring and use of standard treatment algorithms to identify and treat toxic effects after a rechallenge after irAEs in patients receiving ICI therapy.
